World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
20433
World Ranking
13360
National Ranking
6794

Raymond K. Mulhern publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raymond K. Mulhern sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 189 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raymond K. Mulhern D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond K. Mulhern sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raymond K. Mulhern was affiliated with St. Jude Children's Research Hospital in the United States. Their career included contributions to scientific research within this institution, which is known for its focus on pediatric diseases and cancer research.

Though specific details regarding their recent papers, including titles, years, and venues, are not available, Raymond K. Mulhern's work was situated within an academic landscape connected to St. Jude Children's Research Hospital.

No information regarding frequent co-authors or publication venues linked to their research is documented. Similarly, there are no records of book publications or specific areas of study such as main fields, subfields, or topics prominently tied to their work.

There is no record of awards won, and no specific years or citations related to honors or recognitions are provided.

Raymond K. Mulhern is deceased.

Best Publications

  • Late neurocognitive sequelae in survivors of brain tumours in childhood.

    Raymond K Mulhern;Thomas E Merchant;Amar Gajjar;Wilburn E Reddick

  • Postoperative Chemotherapy and Delayed Radiation in Children Less Than Three Years of Age With Malignant Brain Tumors

    Patricia K. Duffner;Marc E. Horowitz;Jeffrey P. Krischer;Henry S. Friedman

  • Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.

    R K Mulhern;J L Kepner;P R Thomas;F D Armstrong

  • Neurocognitive Consequences of Risk-Adapted Therapy for Childhood Medulloblastoma

    Raymond K. Mulhern;Shawna L. Palmer;Thomas E. Merchant;Dana Wallace

  • Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

    Shawna L. Palmer;Olga Goloubeva;Wilburn E. Reddick;John O. Glass

  • Social competence and behavioral adjustment of children who are long-term survivors of cancer.

    Raymond K. Mulhern;Abby L. Wasserman;Alice G. Friedman;Diane Fairclough

  • Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study.

    J Ochs;R Mulhern;D Fairclough;L Parvey

  • A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy.

    Robert W. Butler;Donna R. Copeland;Diane L. Fairclough;Raymond K. Mulhern

  • Risks of Young Age for Selected Neurocognitive Deficits in Medulloblastoma Are Associated With White Matter Loss

    Raymond K. Mulhern;Shawna L. Palmer;Wilburn E. Reddick;John O. Glass

  • Craniopharyngioma: The St. Jude Children's Research Hospital experience 1984-2001

    Thomas E Merchant;Erin N Kiehna;Robert A Sanford;Raymond K Mulhern

  • Using Problem-Solving Skills Training to Reduce Negative Affectivity in Mothers of Children With Newly Diagnosed Cancer: Report of a Multisite Randomized Trial.

    Olle Jane Z. Sahler;Diane L. Fairclough;Sean Phipps;Raymond K. Mulhern

  • Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors.

    Wilburn E. Reddick;Wilburn E. Reddick;Holly A. White;John O. Glass;Gregory C. Wheeler

  • A Prospective Comparison of Neuropsychologic Performance of Children Surviving Leukemia Who Received 18-Gy, 24-Gy, or No Cranial Irradiation

    Raymond K. Mulhern;Diane Fairclough;Judith Ochs

  • Preliminary Results From a Phase II Trial of Conformal Radiation Therapy and Evaluation of Radiation-Related CNS Effects for Pediatric Patients With Localized Ependymoma

    Thomas E. Merchant;Raymond K. Mulhern;Matthew J. Krasin;Larry E. Kun

  • Neuropsychological status of children treated for brain tumors: A critical review and integrative analysis

    Raymond K. Mulhern;Janet Hancock;Diane Fairclough;Larry Kun

  • Survival and Neurodevelopmental Outcome of Young Children With Medulloblastoma at St Jude Children's Research Hospital

    Andrew W. Walter;Raymond K. Mulhern;Amar Gajjar;Richard L. Heideman

  • Neurocognitive deficits in medulloblastoma survivors and white matter loss

    Raymond K. Mulhern;Raymond K. Mulhern;Wilburn E. Reddick;Wilburn E. Reddick;Shawna L. Palmer;John O. Glass

  • Neurocognitive Interventions for Children and Adolescents Surviving Cancer

    Robert W. Butler;Raymond K. Mulhern

  • Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function

    Thomas E. Merchant;Erin N. Kiehna;Larry E. Kun;Raymond K. Mulhern

  • Problem-solving skills training for mothers of children with newly diagnosed cancer: a randomized trial.

    Olle Jane Z. Sahler;James W. Varni;Diane L. Fairclough;Robert W. Butler

Frequent Co-Authors

Larry E. Kun
Larry E. Kun St. Jude Children's Research Hospital
Thomas E. Merchant
Thomas E. Merchant St. Jude Children's Research Hospital
Amar Gajjar
Amar Gajjar St. Jude Children's Research Hospital
Diane L. Fairclough
Diane L. Fairclough University of Colorado Anschutz Medical Campus
Winfred C. Wang
Winfred C. Wang St. Jude Children's Research Hospital
Sean Phipps
Sean Phipps St. Jude Children's Research Hospital
Lonnie K. Zeltzer
Lonnie K. Zeltzer University of California, Los Angeles
Oscar A. Barbarin
Oscar A. Barbarin University of Maryland, College Park
Melissa M. Hudson
Melissa M. Hudson St. Jude Children's Research Hospital
Robert B. Noll
Robert B. Noll University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Medicine or allied healthcare fields, there are several flexible online degree and certification options. Entry-level nursing remains a popular choice, especially for those seeking a fast start with an adn program. These programs often have streamlined admissions and can lead to entry-level nursing roles in just two years.

For those drawn to administrative healthcare roles, pursuing a degree in healthcare administration can open doors to management positions in hospitals and clinics. These programs often accept transfer credits and offer accelerated options to help students graduate faster.

If you’d like to work behind the scenes in healthcare, consider training through reputable medical billing and coding schools that accept fafsa. This can help make your education more affordable and lead directly to high-demand administrative roles.

Finally, for those interested in practical nursing, some schools offer programs where do you have to take a teas test for lpn is not a requirement, making the pathway to licensure more accessible. Exploring these related degrees can help you find the healthcare career path that best matches your goals and interests.

Best Scientists Citing Raymond K. Mulhern

Recently Published Articles